Subject: This News Will Set the Stock on Fire Read All About it Inside

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
This is the news that PZOO has been working on for several months and will take their business to a whole new level.
Hot Stock to WatchHot Stock to Watch

Company: Pazoo Inc. (Pink Sheets: PZOO)


Price: 0.0033

Change (%): + 0.0006 (22.22)

Volume: 96,257,873
PZOO Chart

Pazoo Expects To Begin Generating Commissioned Based Revenue As Harris Lee Colorado Enters Into Operational Advisory Agreement For Denver Colorado Testing Lab

WHIPPANY, N.J., Oct. 29, 2015 /PRNewswire/ - Pazoo, Inc. (OTC Pinks: PZOO) (German WKN#: A1J3DK), is pleased to announce that for the first time Pazoo will soon begin generating revenue on a commission basis from the operations of a marijuana testing lab. Harris Lee Colorado (HLCO), Pazoo’s licensee for marijuana testing using Steep Hill’s leading technology and methodology last week reached an agreement in principal to enter into a consulting and operational advisory agreement for an already existing and operational Denver Colorado Marijuana Testing Lab owned by Front Range Analytics, LLC. Harris Lee Colorado (HLCO) has begun generating revenue from the testing lab through a management agreement.

This milestone event is being greatly enhanced due to the activities of the sales teams from Pazoo’s wholly-owned subsidiary CK Distribution, LLC (CK). Over the past few months the CK sales team had received numerous commitments from growers to test at the Denver facility once HLCO completed the interim step of becoming the manager to oversee and make sure that the marketing, sales, testing and overall management of the facility is being properly handled until the final approval from the MED for the complete transfer of the license.

Since HLCO personnel began its marketing efforts, the number of tests increased by approximately 50%. The Denver testing lab is expected to see a growth of 400% in the next couple of months from the approximate 200 tests to about 800 tests per month. Additionally the lab was only authorized for one test (potency) and two weeks ago applied for, and is expect to soon have, the certification for RSA (resident solvent analysis). Over the next few months the lab is expected to apply for and obtain the certifications for two more tests making HLCO one of only 3 labs in Colorado certified for all 4 tests. Once all 4 certifications are obtained, HLCO would expect to experience further strong gains in number of tests and revenue.

The change of ownership meeting that HLCO and Front Range had with the MED on October 14th resulted in the submission of a complete application for HLCO to provide full management services to Front Range. The meeting was very short and the MED confirmed that all paperwork was received. Pazoo expects the MED to approve the change of ownership for HLCO to qualify as an owner of the marijuana testing lab license. The next step in the process is to then submit for the 100% change in ownership and official transfer of the license. Once this occurs, revenue under the HLCO license will transition from the current consulting fee to operational revenue which will dramatically increase revenue being recorded by HLCO. However, this interim step of taking over the management of the facility will allow HLCO to start obtaining the remaining certifications as well as secure new growers to greatly enhance revenue growth.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks